Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobile Delivery of PrEP at a Syringe Services Program
NCT04782180Phase 4Completed
- Sponsor
- University of Miami
- Start
- Feb 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by University of Miami. Started Feb 2022; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04782180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04782180.